Greg Hamilton is the CEO of Accellix Inc. and serves as a board member at io9 Inc. and EraCal Therapeutics. Between 2016 and 2023, they were the CEO of Epigenomics AG and previously held leadership roles at companies like AltheaDx and RGTN Inc. Hamilton's extensive background includes positions as Chief Operating Officer and Chief Financial Officer at Enigma Diagnostics and Vice President at Hologic and Third Wave Technologies. They earned a Bachelor of Science in Finance from Purdue University and an MBA from The University of Chicago Booth School of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices